|
Index of reports
> Cases with Platelet Count Decreased ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Velcade (Bortezomib) where reactions include platelet count decreased. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of Next >>
Possible Velcade side effects in female
Reported by a physician from Japan on 2012-08-22
Patient: female, weighing 51.0 kg (112.2 pounds)
Reactions: Cheyne-Stokes Respiration, Cardiac Failure, Pain, Depressed Level of Consciousness, Platelet Count Decreased, Cardiac Amyloidosis, Liver Disorder
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Fentanyl-100
Indication: Cancer Pain
Start date: 2012-04-25
End date: 2012-04-25
Velcade
Start date: 2012-03-26
Velcade
Start date: 2012-03-19
Velcade
Indication: Multiple Myeloma
End date: 2012-04-19
Velcade
Indication: Renal Amyloidosis
Start date: 2012-03-23
Velcade
End date: 2012-04-19
Velcade
Start date: 2012-03-19
Velcade
End date: 2012-04-12
Velcade
Start date: 2012-03-23
Velcade
Start date: 2012-03-26
Velcade
End date: 2012-04-12
Velcade
Start date: 2012-03-26
Velcade
Start date: 2012-03-16
Velcade
Start date: 2012-03-23
Velcade
End date: 2012-04-16
Velcade
End date: 2012-04-12
Velcade
End date: 2012-04-09
Velcade
Start date: 2012-03-16
Velcade
End date: 2012-04-09
Velcade
Start date: 2012-03-19
Velcade
End date: 2012-04-09
Velcade
End date: 2012-04-16
Velcade
Indication: Cardiac Amyloidosis
End date: 2012-04-19
Velcade
End date: 2012-04-16
Velcade
Start date: 2012-03-16
Other drugs received by patient: Zyvox; Dopamine HCL; Carvedilol; Tolvaptan; Losartan Potassium; Amiodarone HCL; Dexamethasone Acetate; Lasix; Albumin (Human); Lasix; Azosemide; Forsenid; Trichlormethiazide; Valtrex; Fentanyl Citrate; Azosemide; Eplerenone; AN Unknown Medication; Losartan Potassium; Omeprazole
Possible Velcade side effects in 71 year old male
Reported by a physician from United States on 2012-08-20
Patient: 71 year old male, weighing 63.0 kg (138.6 pounds)
Reactions: Diarrhoea, Haemorrhage Intracranial, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
End date: 2012-08-03
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-25
End date: 2012-08-03
Other drugs received by patient: Laxatives
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-17
Patient:
Reactions: Cheyne-Stokes Respiration, Cancer Pain, Pain, Cardiac Amyloidosis, Staphylococcal Sepsis, Liver Disorder, Cardiac Failure, Platelet Count Decreased, Depressed Level of Consciousness, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Fentanyl
Dosage: 12.5 unk, unk
Indication: Cancer Pain
Start date: 2012-04-25
End date: 2012-04-25
Velcade
Dosage: 1.824 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2012-03-16
End date: 2012-04-12
Velcade
Indication: Renal Amyloidosis
Velcade
Indication: Cardiac Amyloidosis
Other drugs received by patient: Human Albumin / 01102501 /; Dexamethasone; Losartan Potassium; Furosemide; Eplerenone; Omeprazole; Zyvox; Sennoside / 00571902 /; Dopamine HCL; Pursennid / 00142207 /; Losartan Potassium; Furosemide; Amiodarone Hydrochloride; Valaciclovir; Azosemide; Daikenchuto; Carvedilol; Trichlormethiazide; Azosemide; Tolvaptan
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-07
Patient:
Reactions: Cheyne-Stokes Respiration, Cancer Pain, Cardiac Amyloidosis, Staphylococcal Sepsis, Liver Disorder, Cardiac Failure, Depressed Level of Consciousness, Platelet Count Decreased, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Velcade
Indication: Cardiac Amyloidosis
Velcade
Indication: Renal Amyloidosis
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2012-03-16
End date: 2012-04-12
Other drugs received by patient: Losartan Potassium; Eplerenone; Daikenchuto; Dopamine HCL; Azosemide; Sennoside / 00571902 /; Azosemide; Pursennid / 00142207 /; Valaciclovir; Omeprazole; Dexamethasone; Tolvaptan; Artist; Amiodarone Hydrochloride; Human Albumin / 01102501 /; Furosemide; Zyvox; Trichlormethiazide
Possible Velcade side effects in
Reported by a physician from Japan on 2012-08-06
Patient:
Reactions: Cheyne-Stokes Respiration, Cardiac Failure, Depressed Level of Consciousness, Platelet Count Decreased, Cardiac Amyloidosis, Staphylococcal Sepsis, Septic Shock, Liver Disorder
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2012-03-16
End date: 2012-04-12
Velcade
Indication: Cardiac Amyloidosis
Velcade
Indication: Renal Amyloidosis
Other drugs received by patient: Losartan Potassium; Furosemide; Azosemide; Pursennid / 00142207 /; Zyvox; Amiodarone HCL; Daikenchuto; Human Albumin / 01102501 /; Azosemide; Sennoside / 00571902 /; Eplerenone; Valaciclovir; Omeprazole; Dopamine HCL; Dexamethasone; Artist; Trichlormethiazide; Tolvaptan
Possible Velcade side effects in
Reported by a physician from Japan on 2012-07-31
Patient:
Reactions: Neuropathy Peripheral, Posterior Reversible Encephalopathy Syndrome, Platelet Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Ursodiol; Lanadexon / 00016001 /; Oxycontin; Vfend; Kaywan; Oxinorm / 00547301 /; Acetaminophen; Famotidine; Magmitt
Possible Velcade side effects in
Reported by a consumer/non-health professional from Japan on 2012-07-27
Patient:
Reactions: Vomiting, Amylase Increased, Platelet Count Decreased, Lipase Increased, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Januvia
Dosage: unk
Administration route: Oral
Velcade
Dosage: 1.3 mg/m2, unk
Other drugs received by patient: Dexamethasone
Possible Velcade side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 50.8 kg (111.7 pounds)
Reactions: Blood Calcium Decreased, Pneumonia, Platelet Count Decreased, Blood Magnesium Decreased, Clostridial Infection
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, 1/week
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-06
Revlimid
Dosage: 25 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-06-05
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2012-05-01
Velcade
Dosage: 0.1 mg, 1/week
Start date: 2012-06-05
Other drugs received by patient: Zometa
Possible Velcade side effects in female
Reported by a physician from United States on 2012-07-06
Patient: female, weighing 92.0 kg (202.4 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Anaemia, Febrile Neutropenia, Muscular Weakness, Acidosis, Renal Failure Chronic, Fatigue, Sepsis, Platelet Count Decreased, Hypoxia, Neutrophil Count Decreased, Lymphocyte Count Decreased, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-02
End date: 2012-06-08
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-02
End date: 2012-06-06
Possible Velcade side effects in
Reported by a physician from Japan on 2012-06-29
Patient:
Reactions: Cardiac Failure, Depressed Level of Consciousness, Platelet Count Decreased, Cardiac Amyloidosis, Staphylococcal Sepsis, Liver Disorder
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Multiple Myeloma
Start date: 2012-03-16
End date: 2012-04-12
Velcade
Indication: Renal Amyloidosis
Velcade
Indication: Cardiac Amyloidosis
Other drugs received by patient: Valaciclovir; Azosemide; Furosemide; Dexamethasone; Tolvaptan; Daikenchuto; Pursennid / 00142207 /; Carvedilol; Eplerenone; Trichlormethiazide; Human Albumin / 01102501 /; Omeprazole; Amiodarone Hydrochloride; Losartan Potassium; Azosemide; Zyvox
Possible Velcade side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-22
Patient: female, weighing 77.6 kg (170.6 pounds)
Reactions: Haemoglobin Decreased, Brain Natriuretic Peptide Increased, Chest Pain, Mitral Valve Incompetence, Platelet Count Decreased, Hypoaesthesia, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 375 mg/m2, cyclic
Indication: Renal Transplant
Start date: 2012-01-24
End date: 2012-01-24
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Renal Transplant
Start date: 2012-01-31
End date: 2012-02-21
Other drugs received by patient: Epoetin; Pantoprazole; Nephrocaps; Calcium Acetate; Metoprolol; Gabapentin; Nasonex; Estraderm
Possible Velcade side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-22
Patient: male, weighing 101.6 kg (223.5 pounds)
Reactions: Urinary Tract Infection, Pain, Mental Status Changes, Neoplasm Progression, Mantle Cell Lymphoma, Haemodialysis, Lymphocytosis, Cardiac Failure, Platelet Count Decreased, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Temsirolimus
Dosage: 25 mg weekly iv
Indication: Mantle Cell Lymphoma
Start date: 2012-04-04
End date: 2012-05-16
Velcade
Dosage: 1.6 mg/m2 weekly iv
Indication: Mantle Cell Lymphoma
Start date: 2012-04-04
End date: 2012-05-16
Possible Velcade side effects in female
Reported by a consumer/non-health professional from United States on 2012-06-20
Patient: female, weighing 92.0 kg (202.4 pounds)
Reactions: White Blood Cell Count Decreased, Dyspnoea, Anaemia, Muscular Weakness, Acidosis, Renal Failure Chronic, Fatigue, Sepsis, Platelet Count Decreased, Hypoxia, Neutrophil Count Decreased, Lymphocyte Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Decitabine
Dosage: 20 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-02
End date: 2012-06-08
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-02
End date: 2012-06-06
Possible Velcade side effects in
Reported by a physician from Japan on 2012-06-12
Patient:
Reactions: Neuropathy Peripheral, Posterior Reversible Encephalopathy Syndrome, Platelet Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Magmitt; Kaywan; Acetaminophen; Oxycontin; Oxinorm / 00547301 /; Famotidine; Lanadexon / 00016001 /; Vfend; Ursodiol
Possible Velcade side effects in
Reported by a physician from Austria on 2012-06-08
Patient:
Reactions: White Blood Cell Count Decreased, Platelet Count Decreased, Sjogren's Syndrome
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Tropisetron Hydrochloride; Sodium Chloride
Possible Velcade side effects in
Reported by a consumer/non-health professional from Japan on 2012-06-04
Patient:
Reactions: Rectal Cancer, Platelet Count Decreased, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Aspirin; Decadron; Onealfa; Calcium Carbonate; Lantus; Lansoprazole; Valtrex; Novorapid
Possible Velcade side effects in
Reported by a pharmacist from Japan on 2012-06-01
Patient:
Reactions: Platelet Count Decreased, Neutrophil Count Decreased, Septic Shock
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Oxycontin; Valtrex; Fentanyl-100; Oxinorm / 00547301 /; Oxinorm / 00547301 /; Coniel; Candesartan Cilexetil; Nateglinide; Plavix; Melphalan Hydrochloride; Prednisolone; Bisoprolol Fumarate; Aspirin; Pursennid / 00142207 /; Celecoxib; Lansoprazole; Novamin / 00013301 /; Voltaren; Levotomin / 00038602 /
Possible Velcade side effects in
Reported by a physician from Japan on 2012-05-31
Patient:
Reactions: Neuropathy Peripheral, Posterior Reversible Encephalopathy Syndrome, Platelet Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Magmitt; Oxinorm / 00547301 /; Vfend; Lanadexon / 00016001 /; Ursodiol; Famotidine; Acetaminophen; Oxycontin; Kaywan
Possible Velcade side effects in 56 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25
Patient: 56 year old male
Reactions: Haematocrit Decreased, Dyspnoea, RED Blood Cell Count Decreased, Palpitations, Platelet Count Decreased, Heart Rate Irregular, Asthenia, Blood Glucose Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 200 mg, daily, iv
Indication: Multiple Myeloma
Start date: 2011-09-02
End date: 2011-11-19
Decadron
Dosage: 40 mg, wky, unk
Indication: Multiple Myeloma
Start date: 2011-09-02
End date: 2011-11-19
Revlimid
Dosage: 15 mg, daily, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-02
End date: 2011-11-19
Velcade
Dosage: 1.3 mg/m2, unk, iv
Indication: Multiple Myeloma
Start date: 2011-09-02
End date: 2011-11-19
Other drugs received by patient: Digoxin
Possible Velcade side effects in
Reported by a physician from Korea, Republic of on 2012-05-23
Patient:
Reactions: Death, Platelet Count Decreased, Cerebral Haemorrhage
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Dextrose
Possible Velcade side effects in 18 year old male
Reported by a physician from United States on 2012-05-10
Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-24
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Pegaspargase
Dosage: 2500 iu, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-25
End date: 2012-03-02
Prednisone TAB
Dosage: 50 mg, bid
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-04
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Vincristine
Dosage: 2 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Possible Velcade side effects in 77 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-17
Patient: 77 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Haemoglobin Decreased, Platelet Count Decreased, Febrile Neutropenia, Constipation, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Decadron
Administration route: Oral
Start date: 2011-03-29
End date: 2011-04-08
Velcade
Dosage: twice a week
Indication: Multiple Myeloma
Start date: 2011-03-29
End date: 2011-04-05
Other drugs received by patient: Gabapentin; Tramadol Hydrochloride; Simvastatin
Possible Velcade side effects in 18 year old male
Reported by a consumer/non-health professional from United States on 2012-04-13
Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-24
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Pegaspargase
Dosage: 2500 iu, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-25
End date: 2012-03-02
Prednisone TAB
Dosage: 50 mg, bid
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-04
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Vincristine
Dosage: 2 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Possible Velcade side effects in
Reported by a physician from Japan on 2012-04-13
Patient:
Reactions: Amylase Increased, Vomiting, Platelet Count Decreased, Pyrexia, Lipase Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Sitagliptin Phosphate
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Velcade
Dosage: 1.3 mg/m2, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-04
End date: 2012-01-04
Other drugs received by patient: Dexamethasone
Possible Velcade side effects in 18 year old male
Reported by a physician from United States on 2012-04-03
Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)
Reactions: White Blood Cell Count Decreased, Abdominal Pain, Metabolic Acidosis, Clostridium Test Positive, Urine Output Decreased, Hypotension, Hyponatraemia, Capillary Leak Syndrome, Platelet Count Decreased, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 70 mg;x1;inth
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
Doxorubicin HCL
Dosage: 60 mg/m**2;x1;iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-02-24
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: inth
Indication: Acute Lymphocytic Leukaemia
Oncaspar
Dosage: 2500 iu;x1;iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Prednisone TAB
Dosage: 20 mg/m**2;qd;po
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-04
Velcade
Dosage: 1.3 mg/m**2; qd; iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Vincristine
Dosage: 1.5 mg/m**2;qd;iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Possible Velcade side effects in
Reported by a consumer/non-health professional from Japan on 2012-04-03
Patient:
Reactions: Rectal Cancer, Rectal Ulcer Haemorrhage, Platelet Count Decreased, Multiple Myeloma
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Velcade
Other drugs received by patient: Calcium Carbonate; Onealfa; Decadron; Lansoprazole; Lantus; Valtrex; Aspirin; Novorapid
Possible Velcade side effects in male
Reported by a consumer/non-health professional from France on 2012-03-30
Patient: male, weighing 95.0 kg (209.0 pounds)
Reactions: Weight Decreased, Libido Disorder, Eczema, DRY Skin, Myalgia, Lung Disorder, Neuropathy Peripheral, Platelet Count Decreased, Influenza
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 2.5 milligram
Administration route: Oral
Start date: 2011-09-01
Revlimid
Dosage: 1.5 milligram
Administration route: Oral
Velcade
Dosage: .5714 milligram
Start date: 2011-09-01
Other drugs received by patient: Bactrim; Aspegic 1000; Dexamethasone; Fluconazole; Amlodipine Besylate; Acyclovir; Lyrica; Oxycontin; Phenoxymethyl Penicillin; Oxycodone HCL
Possible Velcade side effects in 74 year old male
Reported by a physician from United States on 2012-03-23
Patient: 74 year old male
Reactions: Dyspnoea, Fatigue, Platelet Count Decreased, Cardiac Failure Congestive
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25 mg, daily for 14d, then off for 7d q21d, po 10 mg, daily x 14 days, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-18
End date: 2011-08-01
Revlimid
Dosage: 25 mg, daily for 14d, then off for 7d q21d, po 10 mg, daily x 14 days, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-08-24
Velcade
Dosage: 1.3 mg/m2, days 1, 4, 8, 11 q 21 days, iv 1 mg/m2, days 1, 4, 8, 11 q 21 days, iv
Indication: Multiple Myeloma
Start date: 2011-04-18
End date: 2011-07-18
Velcade
Dosage: 1.3 mg/m2, days 1, 4, 8, 11 q 21 days, iv 1 mg/m2, days 1, 4, 8, 11 q 21 days, iv
Indication: Multiple Myeloma
Start date: 2011-09-06
Other drugs received by patient: Digoxin (Digoxin) (Tablets); Synthroid; Acetaminophen (Paracetamol) (Tablets); Advair Diskus (Seretide Mite) (Inhalant); Iron (Iron) (Unknown); Spiriva; Emla (Emla) (Cream); Prochlorperazine Maleate (Prochlorperazine Maleate) (Tablets); Celexa; Benadryl / Nystatin / Fluocinolone (All Other Therapeutic Products) (Solut; Aspirin; Albuterol Sulfate (Salbutamol Sulfate) (Inhalant); MAG-Oxide (Magnesium Oxide) (Tablets); Dexamethasone; Vicodin; Bactrim DS; Levothyroxine (Levothyroxine) (Tablets); Tamsulosin HCL (Tamsulosin Hydrochloride) (Capsules); Metoprolol (Metoprolol) (Tablets); Allopurinol
Possible Velcade side effects in 71 year old male
Reported by a individual with unspecified qualification from United States on 2012-03-23
Patient: 71 year old male, weighing 97.5 kg (214.6 pounds)
Reactions: White Blood Cell Count Decreased, Staphylococcal Infection, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, daily
Indication: Chemotherapy
Start date: 2011-10-24
Insulin (Insulin) (Unknown)
Dosage: 3.5 mg, as needed,
Indication: Type 1 Diabetes Mellitus
Start date: 2011-10-24
Revlimid
Dosage: see image
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-06-01
Revlimid
Dosage: see image
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-09-16
Velcade
Dosage: 3.5 mg, day 1, 4, 8, 11 q 21 days,
Indication: Multiple Myeloma
Start date: 2011-10-24
Other drugs received by patient: Acyclovir; Ciprofloxacin; Vancomycin
Possible Velcade side effects in
Reported by a physician from Japan on 2012-03-23
Patient:
Reactions: Haemoglobin Decreased, Pneumonia, Gastroenteritis, Platelet Count Decreased, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 20 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-11-07
Panobinostat
Dosage: 15 mg, 3/week
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-11-07
Velcade
Dosage: 1.7 mg, 2/week
Indication: Multiple Myeloma
Start date: 2011-11-07
Velcade
Dosage: 1 mg/m2, unk
Start date: 2011-12-05
Other drugs received by patient: Allopurinol; Amlodipine; Lendormin; Rabeprazole Sodium; Valtrex; Methycobal / 00324901 /; Magmitt; Olmesartan Medoxomil; Sennoside / 00571902 /
Page 1 Next >>
|
